Mast cells have prognostic value in Merkel cell carcinoma

American Journal of Dermatopathology

Volumn 30, Issue 1, 2008, Pages 27-30

  Beer, Trevor W ^a   Ng, Lydia B ^b   Murray, Kevin ^c  

^a Cutaneous Pathology   (Australia)

^b ST JOHN OF GOD HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Immunohistochemistry; Mast cells; Merkel cell carcinoma; Prognosis; Tryptase

Indexed keywords

TRYPTASE;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL COUNT; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MALE; MAST CELL; MERKEL CELL TUMOR; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; CELL COUNT; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MAST CELLS; MIDDLE AGED; PROGNOSIS; SKIN NEOPLASMS;

EID: 38549094141     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31815c932a     Document Type: Article

References (35)

1. Hitchcock CL, Bland KI, Laney RG III, et al. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg. 1988;207:201-207.
2. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2004;89:1-4.
3. McKee PH, Calonje E, Granter SR. The structure and function of skin. In: Pathology of the Skin. 3rd ed. Philadelphia, PA: Elsevier Mosby; 2005: 18-20.
4. Allen PJ, Bowne WB, Jaques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23:2300-2309.
5. Llombart B, Monteagudo C, López-Guerrero JA, et al. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology. 2005;10:1-13.
6. Ch'ng S,Wallis RA, Yuan L, et al. Mast cells and cutaneous malignancies. Mod Pathol. 2006;19:149-159.
7. Veness MJ. Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma): an overview of management. Australas J Dermatol. 2006;47:160-165.
8. Eng TY, Boersma MG, Fuller CD, et al. Treatment of Merkel cell carcinoma. Am J Clin Oncol. 2004;27:510-515.
9. Eng TY, Naguib M, Fuller CD, et al. Treatment of recurrent Merkel cell carcinoma: an analysis of 46 cases. Am J Clin Oncol. 2004;27:576-583.
10. Dancey AL, Rayatt SS, Soon C, et al. Merkel cell carcinoma: a report of 34 cases and literature review. J Plast Reconstr Aesthet Surg. 2006;59:1294-1299.
11. Costa JJ,Weller PF, Galli SJ. The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA. 1997;278:1815-1822.
12. Walls AF, Jones DB, Williams JH, et al. Immunohistochemical identification of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase. J Pathol. 1990;162:119-126.
13. Ribatti D, Ennas MG, Vacca A, et al. Tumor vascularity and tryptase positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest. 2003;33:420-425.
14. Elpek GÖ, Gelen T, Aksoy NH, et al. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J Clin Pathol. 2001;54:940-944.
15. Takanami I, Takeuchi K, Naruke M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer. 2000;88:2686-2692.
16. Toth-Jakatics R, Jimi S, Takebayashi S, et al. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. Hum Pathol. 2000;31:955-960.
17. Dabiri S, Huntsman D, Makretsov N, et al. The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis. Mod Pathol. 2004;17:690-695.
18. Tomita Y, Aozasa K, Myoui A, et al. Histologic grading in soft-tissue sarcomas. An analysis of 194 cases including AgNOR count and mast-cell count. Int J Cancer. 1993;54:194-199.
19. Duncan LM, Richards LA, Mihm MC Jr. Increased mast cell density in invasive melanoma. J Cutan Pathol. 1998;25:11-15.
20. Brown JK, Jones CA, Rooney LA, et al. Tryptase's potent mitogenic effects in human airway smooth muscle cells are via nonproteolytic actions. Am J Physiol Lung Cell Mol Physiol. 2002;282:L197-L206.
21. Abraham WM. Tryptase: potential role in airway inflammation and remodeling. Am J Physiol Lung Cell Mol Physiol. 2002;282:L193-L196.
22. Beer TW, Baldwin H, West L, et al. Mast cells at pathological and surgical scar sites. Br J Ophthalmol. 1998;82:691-694.
23. Carson HJ, Reddy V, Taxy JB. Proliferation markers and prognosis in Merkel cell carcinoma. J Cutan Pathol. 1998;25:16-19.
24. Koljonen V, Tukiainen E, Haglund C, et al. Proliferative activity detected by Ki67 correlates with poor outcome in Merkel cell carcinoma [letter]. Histopathology. 2006;49:551-553.
25. Fernández-Figueras MT, Puig L, Musulen E, et al. Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinoma. Histopathology. 2005;45:614-621.
26. Erickson LA, Papotti M, Volante M, et al. Merkel cell carcinomas: expression of S-phase kinase-associated protein 2 (Skp2), p27, and proliferation markers. Endocr Pathol. 2003;14:221-229.
27. Parrado C, Bjornhagen V, Eusebi V, et al. Prognosticating tools in primary neuroendocrine (Merkel-cell) carcinomas of the skin: histopathological subdivision, DNA cytometry, cell proliferation analyses (Ki-67-immunoreactivity) and NCAM immunohistochemistry. A clinicopathological study in 25 patients. Pathol Res Pract. 1998;194:11-23.
28. Skelton HG, Smith KJ, Hitchcock CL, et al. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol. 1997;37:734-739.
29. Smith PD, Patterson JW. Merkel cell carcinoma (neuroendocrine carcinoma of the skin). Am J Clin Pathol. 2001;115(Suppl):68-78.
30. Tai PT, Yu E, Tonita J. Merkel cell carcinoma of the skin. J Cutan Med Surg. 2000;4:186-195.
31. Koljonen V, Bohling T, Granhroth G, et al. Merkel cell carcinoma: a clinicopathological study of 34 patients. Eur J Surg Oncol. 2003;29:607-610.
32. Mott RT, Smoller BR, Morgan MB. Merkel cell carcinoma: a clinicopathologic study with prognostic implications. J Cutan Pathol. 2004;31:217-223.
33. Sandel HD IV, Day T, Richardson MS, et al. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival? Laryngoscope. 2006;116:791-795.
34. Pitale M, Sessions RB, Husain S. An analysis of prognostic factors in cutaneous neuroendocrine carcinoma. Laryngoscope. 1992;102:244-249.
35. Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg. 2001;127:149-154.